Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
2.
J Ethnopharmacol ; 324: 117806, 2024 Apr 24.
Article in English | MEDLINE | ID: mdl-38278373

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Monteverdia ilicifolia (Maytenus ilicifolia, Celastraceae), known as "espinheira-santa", has been widely used in Brazil to manage mainly gastrointestinal diseases. This species has been listed in the Brazilian Pharmacopeia and in the National List of Essential Medicines (RENAME). Considering that clinical studies about M. ilicifolia are rare, our group has been performing a broader project designed to evaluate the efficacy of M. ilicifolia capsules in a clinical trial, for this reason, approaches to provide safety to those patients are relevant. AIM OF THE STUDY: We aimed to investigate the potential pharmacokinetic interaction and hepatotoxicity and intestinal toxicity of an aqueous extract of M. ilicifolia and its main phytocompounds, catequin, epicatequin, and quercetin. METHODS AND MATERIALS: Slices of liver and intestine of Wistar rats were incubated with different concentrations of M. ilicifolia extract or isolated compounds (catechin, epicatechin and quercetin). Commercial kits were used to evaluate enzyme activities of CYP2D6 and CYP3A4 isoforms, as well as cell viability (MTT) assay and intracellular enzymes leakage, specifically lactate dehydrogenase (LDH), alkaline phosphatase (AP), aspartate aminotransferase (AST), alanine aminotransferase (ALT) were studied. RESULTS: Incubation with M. ilicifolia extract, catechin, epicatechin and quercetin did not affect significantly any evaluated parameter in intestines. The intracellular enzymes leakages, CYP2D6, LDH and AST, were increased with M. ilicifolia extract and quercetin in liver slices. CONCLUSIONS: Our in vitro findings highlighted, for the first time, the potential hepatotoxicity induced by an aqueous extract of M. ilicifolia, consequently this species and its products should be avoided in liver diseases, supporting that studies of safety must be performed including in the context of traditional medicinal plants.


Subject(s)
Catechin , Celastraceae , Chemical and Drug Induced Liver Injury , Maytenus , Plants, Medicinal , Humans , Rats , Animals , Brazil , Plant Extracts/toxicity , Quercetin , Cytochrome P-450 CYP2D6 , Rats, Wistar
3.
Phytother Res ; 37(11): 5354-5365, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37583121

ABSTRACT

We evaluated the impact of an Achyrocline satureioides inflorescence infusion on the clinical outcomes of viral respiratory infections, including those caused by SARS-CoV-2, in a monocentric, randomized, open-label, placebo-controlled clinical trial. Patients with symptoms of viral respiratory infection, including suspected cases of COVID-19, were included and assigned to receive either A. satureioides (n = 57) or Malus domestica (n = 67) infusions twice a day for 14 days. All participants were included before the RT-PCR results, performed using a nasopharyngeal swab. The patients were further divided into subgroups according to real-time polymerase chain reaction results: SARS-CoV-2-positive and SARS-CoV-2-negative subgroups for statistical analyses. We assessed clinical outcomes, such as the latency to resolution of cough, dyspnea, fever, sore throat, chest pain, smell and taste dysfunctions, diarrhea, nausea, abdominal pain, and loss of appetite; hospitalization; and mortality with questionnaires and medical records. The subjects that received early A. satureioides infusion showed a significant reduction in the average number of days with respiratory and neurological symptoms compared with the control group (M. domestica infusion). We conclude that A. satureioides is a safe agent and, in combination with standard care, improves viral respiratory infection symptoms, especially those related to COVID-19.


Subject(s)
Achyrocline , COVID-19 , Humans , SARS-CoV-2 , Research Design , Combined Modality Therapy , Treatment Outcome
5.
J Nutr Biochem ; 60: 35-46, 2018 10.
Article in English | MEDLINE | ID: mdl-30064014

ABSTRACT

Folic acid (FA) supplementation (400 µg/day) has been recommended during pregnancy to prevent neural tube defects. However, in some countries, flours are required to be fortified with FA, possibly increasing the levels of this vitamin in pregnant women. Our previous studies have evidenced a dual effect of the FA treatment in a rat model of neonatal hypoxia-ischemia (HI). Aiming to better correlate with humans, this paper evaluated the effects of two different levels of FA supplementation during pregnancy on memory parameters and neuronal survival and plasticity in the hippocampus of rats submitted to the neonatal HI. During pregnancy, female Wistar rats received one of these diets: standard (SD), supplemented with 2 mg/kg of FA or with 20 mg/kg of FA. At the 7th PND, rats suffered the HI procedure. At the 60th PND rats were evaluated in the open field, Morris water maze, novel-object recognition and inhibitory avoidance tasks. Furthermore, neuronal density, synaptophysin densitometry and BDNF concentration were assessed in the hippocampus. Both doses of FA prevented the HI-induced memory impairments. The supplementation reversed the BDNF late increase in the hippocampus of the HI rats, but did not inhibit the neuronal death. In conclusion, FA supplementation during pregnancy prevented memory deficits and BDNF imbalance after neonatal HI. These findings are particularly relevant because neuroprotection was achieved even in the high level of FA supplementation during pregnancy, indicating that this intervention would be considered secure for the offspring development.


Subject(s)
Animals, Newborn , Brain-Derived Neurotrophic Factor/analysis , Cognitive Dysfunction/prevention & control , Folic Acid/administration & dosage , Hippocampus/chemistry , Hypoxia-Ischemia, Brain/complications , Animals , Brain-Derived Neurotrophic Factor/metabolism , Cognitive Dysfunction/etiology , Dietary Supplements , Female , Maternal-Fetal Exchange , Neuroprotective Agents , Pregnancy , Rats , Rats, Wistar
6.
Vet Parasitol ; 189(2-4): 322-6, 2012 Oct 26.
Article in English | MEDLINE | ID: mdl-22608349

ABSTRACT

Acetylcholinesterase (AChE), an enzyme that hydrolyses acetylcholine (ACh) at cholinergic synapses, is a target for pesticides and its inhibition by organophosphates leads to paralysis and death of arthropods. It has been demonstrated that the n-hexane extract of Calea serrata had acaricidal activity against larvae of Rhipicephalus (Boophilus) microplus and Rhipicephalus sanguineus. The aim of the present study was to understand the mechanism of the acaricidal action of C. serrata n-hexane extract are specifically to investigate the in vitro anticholinesterase activity on larvae of R. microplus and in brain structures of male Wistar rats. The n-hexane extract significantly inhibited in vitro acetylcholinesterase activity in R. microplus larvae and rat brain structures. The results confirm that inhibition of acetylcholinesterase is a possible mechanism of action of hexane extract at C. serrata.


Subject(s)
Asteraceae/chemistry , Brain/drug effects , Cholinesterase Inhibitors/pharmacology , Hexanes/chemistry , Plant Extracts/pharmacology , Rhipicephalus sanguineus/drug effects , Animals , Brain/pathology , Cholinesterase Inhibitors/chemistry , Dose-Response Relationship, Drug , Larva/drug effects , Larva/enzymology , Male , Plant Extracts/chemistry , Rats , Rats, Wistar , Rhipicephalus sanguineus/enzymology
7.
BMC Complement Altern Med ; 12: 41, 2012 Apr 12.
Article in English | MEDLINE | ID: mdl-22494845

ABSTRACT

BACKGROUND: Hibiscus tiliaceus L. (Malvaceae) is used in postpartum disorders. Our purpose was to examine the antidepressant, anxiolytic and sedative actions of the methanol extract of H. tiliaceus flowers using animal models. METHODS: Adult male Swiss albino mice were treated with saline, standard drugs or methanol extract of H. tiliaceus and then subjected to behavioral tests. The forced swimming and tail suspension tests were used as predictive animal models of antidepressant activity, where the time of immobility was considered. The animals were submitted to the elevated plus-maze and ketamine-induced sleeping time to assess anxiolytic and sedative activities, respectively. RESULTS: Methanol extract of H. tiliaceus significantly decreased the duration of immobility in both animal models of antidepressant activity, forced swimming and tail suspension tests. This extract did not potentiate the effect of ketamine-induced hypnosis, as determined by the time to onset and duration of sleeping time. CONCLUSION: Our results indicate an antidepressant-like profile of action for the extract of Hibiscus tiliaceus without sedative side effect.


Subject(s)
Antidepressive Agents/therapeutic use , Depression/drug therapy , Hibiscus , Phytotherapy , Plant Extracts/therapeutic use , Sleep/drug effects , Animals , Anti-Anxiety Agents/pharmacology , Anti-Anxiety Agents/therapeutic use , Antidepressive Agents/pharmacology , Behavior, Animal/drug effects , Disease Models, Animal , Hindlimb Suspension , Ketamine/pharmacology , Male , Maze Learning , Mice , Mice, Inbred Strains , Plant Extracts/pharmacology , Swimming
8.
Neurochem Int ; 58(4): 527-32, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21238526

ABSTRACT

Ascorbate, an intracellular antioxidant, has been considered critical for neuronal protection against oxidant stress, which is supported especially by in vitro studies. Besides, it has been demonstrated an age-related decrease in brain ascorbate levels. The aims of the present study were to investigate ascorbate uptake in hippocampal slices from old Wistar rats, as well as its neuroprotective effects in in vitro and in vivo assays. Hippocampal slices from male Wistar rats aged 4, 11 and 24 months were incubated with radiolabeled ascorbate and incorporated radioactivity was measured. Hippocampal slices from rats were incubated with different concentrations of ascorbate and submitted to H(2)O(2)-induced injury, cellular damage and S100B protein levels were evaluated. The effect of chronic administration of ascorbate on cellular oxidative state and astrocyte biochemical parameters in the hippocampus from 18-months-old Wistar rats was also studied. The ascorbate uptake was decreased in hippocampal slices from old-aged rats, while supplementation with ascorbate (2 weeks) did not modify any tested oxidative status in the hippocampus and the incubation was unable to protect hippocampal slices submitted to oxidative damage (H(2)O(2)) from old rats. Our data suggest that the decline of ascorbate uptake might be involved in the brain greater susceptibility to oxidative damage with advancing age and both in vitro and vivo assays suggest that ascorbate supplementation did not protect hippocampal cells.


Subject(s)
Aging/metabolism , Ascorbic Acid/metabolism , Hippocampus/metabolism , Animals , Hydrogen Peroxide/pharmacology , In Vitro Techniques , Male , Rats , Rats, Wistar , Thiobarbituric Acid Reactive Substances/metabolism
9.
Brain Res ; 1247: 188-95, 2009 Jan 09.
Article in English | MEDLINE | ID: mdl-18992724

ABSTRACT

Environmental enrichment recovers memory deficits without affecting atrophy of the hippocampus adult rats submitted to neonatal hypoxia-ischemia (HI). The present study was designed to investigate whether the modulation of brain oxidative status and/or BDNF content, as assessed in adulthood, are involved with the functional neuroprotection caused by environmental enrichment in animals receiving neonatal HI. Male Wistar rats, in the 7th postnatal day, were submitted to the Levine-Rice model of neonatal hypoxia-ischemia, comprising permanent occlusion of the right common carotid artery and a 90 min period of hypoxia (8% O(2)-92% N(2)). Starting 2 weeks after the HI event, animals were stimulated by the enriched environment (1 h/day for 9 weeks). Rats were sacrificed approximately 24 h after the end of enrichment period and some oxidative stress parameters, specifically the free radical levels, macromolecules damage and superoxide dismutase activity, in hippocampus and frontal cortex samples were determined. BDNF levels were also measured in the same encephalic structures. Indexes of macromolecules damage, TBARS levels and total cellular thiols, as well as free radical levels were unchanged in both studied structures. An increased SOD activity in the right hippocampus of HI group maintained in standard environment was found, this effect was reversed in HI enriched group. Moreover, BDNF levels were increased only in the hippocampus of non-stimulated HI group. These results suggest that the environmental enrichment protocol bearing cognitive protection is not associated to increases in BDNF expression nor SOD activity in hippocampus of the rats, as assessed in adulthood, submitted to neonatal hypoxia-ischemia.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Brain/metabolism , Cytoprotection/physiology , Hypoxia-Ischemia, Brain/metabolism , Hypoxia-Ischemia, Brain/therapy , Oxidative Stress/physiology , Animals , Brain/physiopathology , Disease Models, Animal , Energy Metabolism/physiology , Environment , Free Radicals/metabolism , Frontal Lobe/metabolism , Frontal Lobe/physiopathology , Hippocampus/metabolism , Hippocampus/physiopathology , Hypoxia-Ischemia, Brain/physiopathology , Male , Nerve Degeneration/etiology , Nerve Degeneration/physiopathology , Nerve Degeneration/therapy , Rats , Rats, Wistar , Sulfhydryl Compounds/metabolism , Superoxide Dismutase/metabolism , Superoxide Dismutase-1 , Thiobarbituric Acid Reactive Substances/metabolism , Time
10.
Pharmacol Biochem Behav ; 75(3): 645-50, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12895682

ABSTRACT

The cholinergic hypothesis of Alzheimer disease (AD) has provided the rationale for the current pharmacotherapy of this disease, in an attempt to downgrade the cognitive decline caused by cholinergic deficits. Nevertheless, the search for potent and long-acting acetylcholinesterase (AChE) inhibitors that exert minimal side effects to AD patients is still an ongoing effort. Amazonian communities use traditional remedies prepared with Ptychopetalum olacoides (PO, Olacaceae) roots for treating various central nervous system conditions, including those associated with aging. The fact that PO ethanol extract (POEE) has been found to facilitate memory retrieval in the step down procedure in young and aged mice prompt us to evaluate its effects on AChE activity in memory relevant brain areas. POEE significantly inhibited AChE activity in vitro in a dose- and time-dependent manner in rat frontal cortex, hippocampus and striatum; a significant inhibition was also found in these same brain areas of aged (14 months) mice after acute administration of POEE (100 mg/kg ip). We propose that such AChE inhibitory activity is a neurochemical correlate of a number of therapeutic properties traditionally claimed for P. olacoides, particularly those associated with cognition.


Subject(s)
Brain/drug effects , Cholinesterase Inhibitors/pharmacology , Olacaceae , Plants, Medicinal/chemistry , Animals , Brain/enzymology , Brazil , Cholinesterase Inhibitors/isolation & purification , Cholinesterase Inhibitors/therapeutic use , Cognition Disorders/drug therapy , Cognition Disorders/enzymology , Dose-Response Relationship, Drug , Male , Mice , Plant Roots
SELECTION OF CITATIONS
SEARCH DETAIL